Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 12/2021

01-12-2021 | Radiotherapy | Head and Neck

Prognostic models for 1-year survival of NPC after radiotherapy in different ages

Authors: Qu-xia Zhang, Lv-ping Zhuang, Zhong-yang Lin

Published in: European Archives of Oto-Rhino-Laryngology | Issue 12/2021

Login to get access

Abstract

Purpose

Previous studies have shown that approximately 10% of nasopharyngeal cancer (NPC) patients die within a year of disease onset, and that age is an independent predictor. However, no predictive model has been developed. We aimed to establish novel prognostic models to predict the 1-year cancer-specific survival (CSS) of young, middle-aged, and older patients with NPC after radiotherapy.

Methods

The data of 2822 NPC patients who underwent radiotherapy between 2004 and 2015 were reviewed from the surveillance, epidemiology, and end results database. We divided them into young, middle-aged, and older people groups according to age (< 44 years, 45–59 years, and ≥ 60 years, respectively). Multivariate analyses were performed, and prognostic models were constructed.

Results

Multivariate analyses indicated that age, ethnicity, histological subtype, T, and M stage were independent predictors of 1-year CSS in the older people group. In contrast, ethnicity and age were not found to have predictive value in the young and middle-aged groups, respectively. Accordingly, three prognostic models with excellent predictive values were established for the three groups (C-indices: 0.791 [95% CI 0.722–0.859], 0.763 [95% CI 0.721–0.806] and 0.723 [95% CI 0.683–0.763], respectively). These predictive values are higher than those of the eighth edition American joint committee cancer tumor-node-metastasis (TNM) classification system.

Conclusion

Three prognostic models for predicting the 1-year CSS of young, middle-aged, and older NPC patients after radiotherapy showed better predictive power than the TNM classification system. These models may guide treatment strategies and clinical decision-making in different cohorts.
Literature
1.
go back to reference Zhu Y, Song X, Li R, Quan H, Yan L (2019) Assessment of nasopharyngeal cancer in young patients aged ≤ 30 years. Front Oncol 9:1179CrossRef Zhu Y, Song X, Li R, Quan H, Yan L (2019) Assessment of nasopharyngeal cancer in young patients aged ≤ 30 years. Front Oncol 9:1179CrossRef
2.
go back to reference Pan JJ, Ng WT, Zong JF et al (2016) Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122(21):3307–3315CrossRef Pan JJ, Ng WT, Zong JF et al (2016) Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122(21):3307–3315CrossRef
3.
go back to reference Carioli G, Negri E, Kawakita D, Garavello W, La Vecchia C, Malvezzi M (2017) Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: focus on low-risk areas. Int J Cancer 140(10):2256–2264CrossRef Carioli G, Negri E, Kawakita D, Garavello W, La Vecchia C, Malvezzi M (2017) Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: focus on low-risk areas. Int J Cancer 140(10):2256–2264CrossRef
4.
go back to reference Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. The Lancet 394(10192):64–80CrossRef Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. The Lancet 394(10192):64–80CrossRef
5.
go back to reference Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ (2000) Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48(2):329–337CrossRef Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ (2000) Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48(2):329–337CrossRef
6.
go back to reference Kam MK, Chau RM, Suen J, Choi PH, Teo PM (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56(1):145–157CrossRef Kam MK, Chau RM, Suen J, Choi PH, Teo PM (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56(1):145–157CrossRef
7.
go back to reference Jiang F, Jin T, Feng XL, Jin QF, Chen XZ (2015) Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang cancer hospital’s experience. J Cancer Res Ther 11(Suppl 2):C179-184PubMed Jiang F, Jin T, Feng XL, Jin QF, Chen XZ (2015) Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang cancer hospital’s experience. J Cancer Res Ther 11(Suppl 2):C179-184PubMed
8.
go back to reference Li YQ, Tian YM, Tan SH et al (2018) Prognostic model for stratification of radioresistant nasopharynx carcinoma to curative salvage radiotherapy. JCO 36(9):891–899CrossRef Li YQ, Tian YM, Tan SH et al (2018) Prognostic model for stratification of radioresistant nasopharynx carcinoma to curative salvage radiotherapy. JCO 36(9):891–899CrossRef
9.
go back to reference Tang XR, Li YQ, Liang SB et al (2018) Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol 19(3):382–393CrossRef Tang XR, Li YQ, Liang SB et al (2018) Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol 19(3):382–393CrossRef
11.
go back to reference Pan XX, Liu YJ, Yang W, Chen YF, Tang WB, Li CR (2020) Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients. Laryngoscope 130(3):E83–E88CrossRef Pan XX, Liu YJ, Yang W, Chen YF, Tang WB, Li CR (2020) Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients. Laryngoscope 130(3):E83–E88CrossRef
12.
go back to reference Ahmad OE, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M (2000). Age standardization of Rates: a new WHO standard GPE. Discussion Paper Series. Geneva: World Health Organization Ahmad OE, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M (2000). Age standardization of Rates: a new WHO standard GPE. Discussion Paper Series. Geneva: World Health Organization
13.
go back to reference Pfster DG, Spencer S, Adelstein D et al (2019). NCCN Clinical Practice Guidelines in Oncology Pfster DG, Spencer S, Adelstein D et al (2019). NCCN Clinical Practice Guidelines in Oncology
14.
go back to reference Wang CC, Yang CC, Yeh SA et al (2020) The impact of insurance and marital status on survival in patients with nasopharyngeal carcinoma. Biology (Basel). 9(4):84PubMedCentral Wang CC, Yang CC, Yeh SA et al (2020) The impact of insurance and marital status on survival in patients with nasopharyngeal carcinoma. Biology (Basel). 9(4):84PubMedCentral
15.
go back to reference Guo R, Wu H, Wang J et al (2019) Lymph node status and outcomes for nasopharyngeal carcinoma according to histological subtypes: a SEER population-based retrospective analysis. Adv Ther 36(11):3123–3133CrossRef Guo R, Wu H, Wang J et al (2019) Lymph node status and outcomes for nasopharyngeal carcinoma according to histological subtypes: a SEER population-based retrospective analysis. Adv Ther 36(11):3123–3133CrossRef
16.
go back to reference Xu BB, Lu J, Zheng ZF et al (2019) The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data. Gastric Cancer 22(5):1016–1028CrossRef Xu BB, Lu J, Zheng ZF et al (2019) The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data. Gastric Cancer 22(5):1016–1028CrossRef
17.
go back to reference Wu LR, Liu YT, Jiang N et al (2017) Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center. Oral Oncol 69:26–32CrossRef Wu LR, Liu YT, Jiang N et al (2017) Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center. Oral Oncol 69:26–32CrossRef
18.
go back to reference Lv JW, Huang XD, Chen YP et al (2018) A national study of survival trends and conditional survival in nasopharyngeal carcinoma: analysis of the national population-based surveillance epidemiology and end results registry. Cancer res and treat 50(2):324–334CrossRef Lv JW, Huang XD, Chen YP et al (2018) A national study of survival trends and conditional survival in nasopharyngeal carcinoma: analysis of the national population-based surveillance epidemiology and end results registry. Cancer res and treat 50(2):324–334CrossRef
19.
go back to reference Lv JW, Zhou GQ, Chen YP et al (2017) Refining the role of lymph node biopsy in survival for patients with nasopharyngeal carcinoma: population-based study from the surveillance epidemiology and end-results registry. Ann Surg Oncol 24(9):2580–2587CrossRef Lv JW, Zhou GQ, Chen YP et al (2017) Refining the role of lymph node biopsy in survival for patients with nasopharyngeal carcinoma: population-based study from the surveillance epidemiology and end-results registry. Ann Surg Oncol 24(9):2580–2587CrossRef
20.
go back to reference Wu LR, Zhang XM, Xie XD, Lu Y, Wu JF, He X (2019) Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: results from a non-endemic cohort with 10-year follow-up. Oral Oncol. 98:141–146CrossRef Wu LR, Zhang XM, Xie XD, Lu Y, Wu JF, He X (2019) Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: results from a non-endemic cohort with 10-year follow-up. Oral Oncol. 98:141–146CrossRef
21.
go back to reference Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. JCO 26(8):1364–1370CrossRef Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. JCO 26(8):1364–1370CrossRef
22.
go back to reference Dong D, Tang L, Li ZY et al (2019) Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol 30(3):431–438CrossRef Dong D, Tang L, Li ZY et al (2019) Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol 30(3):431–438CrossRef
23.
go back to reference Zhang LL, Huang MY, Li Y et al (2019) Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma. EBioMedicine 42:270–280CrossRef Zhang LL, Huang MY, Li Y et al (2019) Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma. EBioMedicine 42:270–280CrossRef
24.
go back to reference Huang XD, Zhou GQ, Lv JW et al (2018) Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data, intelligence platform-based analysis. Radiother Oncol 129(2):389–395CrossRef Huang XD, Zhou GQ, Lv JW et al (2018) Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data, intelligence platform-based analysis. Radiother Oncol 129(2):389–395CrossRef
25.
go back to reference Wu SG, Lian CL, Wang J et al (2019) The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up. Ann Transl Med 7(23):768CrossRef Wu SG, Lian CL, Wang J et al (2019) The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up. Ann Transl Med 7(23):768CrossRef
26.
go back to reference Liu Z, Chang ET, Liu Q et al (2017) Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area. Cancer 123(14):2716–2725CrossRef Liu Z, Chang ET, Liu Q et al (2017) Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area. Cancer 123(14):2716–2725CrossRef
27.
go back to reference Jørgensen TL, Hallas J, Friis S, Herrstedt J (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106(7):1353–1360CrossRef Jørgensen TL, Hallas J, Friis S, Herrstedt J (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106(7):1353–1360CrossRef
28.
go back to reference García-Lorenzo J, Farre N, Codina A, Gallego O, De Vega M, León X (2017) Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area. Clin Transl Oncol 19(6):777–783CrossRef García-Lorenzo J, Farre N, Codina A, Gallego O, De Vega M, León X (2017) Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area. Clin Transl Oncol 19(6):777–783CrossRef
29.
go back to reference Au KH, Ngan RKC, Ng AWY et al (2018) Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study). Oral Oncol 77:16–21CrossRef Au KH, Ngan RKC, Ng AWY et al (2018) Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study). Oral Oncol 77:16–21CrossRef
30.
go back to reference Tsao SW, Yip YL, Tsang CM et al (2014) Etiological factors of nasopharyngeal carcinoma. Oral Oncol 50(5):330–338CrossRef Tsao SW, Yip YL, Tsang CM et al (2014) Etiological factors of nasopharyngeal carcinoma. Oral Oncol 50(5):330–338CrossRef
31.
go back to reference Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ (2017) Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer 36(1):90CrossRef Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ (2017) Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer 36(1):90CrossRef
Metadata
Title
Prognostic models for 1-year survival of NPC after radiotherapy in different ages
Authors
Qu-xia Zhang
Lv-ping Zhuang
Zhong-yang Lin
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Keyword
Radiotherapy
Published in
European Archives of Oto-Rhino-Laryngology / Issue 12/2021
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-021-06730-8

Other articles of this Issue 12/2021

European Archives of Oto-Rhino-Laryngology 12/2021 Go to the issue